Brian
J. Smith

Brian J. Smith graduated from Loras College in 1977 – B.A. in Business Administration. He went on to obtain an M.B.A. from Dominican University in 1984 and is an Alumnus of The Harvard Business School, having completed the OPM Program in 2006.

Brian began his career in the health care industry as a sales representative for Johnson and Johnson’s Ethicon Division. He joined Boehringer Ingleheim as a hospital sales representative in Chicago where he later relocated to the company’s home office in Ridgefield, Connecticut to take on various cardiovascular marketing positions.

In 1986, Brian joined Lederle Labs’ International Division where he headed up the company’s marketing initiative to launch new cardiovascular products in Europe and the Far East. He went on to hold senior marketing and sales positions at Forest Laboratories, Watson Pharmaceuticals and Boron LePore & Associates. He was a Division President -Corporate Officer of Boron LePore during the IPO in 1998.

Brian has served as CEO and Co-founder of Argent Development Group since 2004. Brian was Co-founder of Manchester Pharmaceuticals which was sold to Retrophin in 2014. Presently, he serves as Co-founder and COO of Melbourne Laboratories, and Co- founder and President of Valcrest Pharmaceuticals.

In addition to Argent, Brian is on the Board of Directors of several privately held pharmaceutical, drug development and health care companies. In 2015, he joined the Board of Directors of DermAvance Pharmaceuticals.

Brian is a member of the Board of Regents for Loras College and is a member of The Executive Committee. Brian is on the Board of Trustees for Cristo Rey High School in Brooklyn New York.